Edgewise Therapeutics Inc (EWTX)
32.41
+0.43
(+1.34%)
USD |
NASDAQ |
Nov 22, 14:14
Edgewise Therapeutics Shareholders Equity (Quarterly): 488.88M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 488.88M |
| June 30, 2024 | 510.47M |
| March 31, 2024 | 534.94M |
| December 31, 2023 | 318.83M |
| September 30, 2023 | 290.43M |
| June 30, 2023 | 311.46M |
| March 31, 2023 | 328.84M |
| December 31, 2022 | 346.72M |
| Date | Value |
|---|---|
| September 30, 2022 | 361.40M |
| June 30, 2022 | 246.36M |
| March 31, 2022 | 260.36M |
| December 31, 2021 | 274.38M |
| September 30, 2021 | 285.40M |
| June 30, 2021 | 296.75M |
| March 31, 2021 | 306.39M |
| December 31, 2020 | -33.42M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-33.42M
Minimum
Dec 2020
534.94M
Maximum
Mar 2024
320.51M
Average
308.92M
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 660.94M |
| Cytokinetics Inc | -13.91M |
| Vanda Pharmaceuticals Inc | 541.22M |
| Vertex Pharmaceuticals Inc | 15.63B |
| Sarepta Therapeutics Inc | 1.221B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 511.28M |
| Total Liabilities (Quarterly) | 22.40M |